Showing results (1511-1520 of 3,021) with videos related to
Sort By:
Pageof 303
Current Pharmaceutical Biotechnology|September 30, 2010
Role of antioxidants in redox regulation of diabetic cardiovascular complicationsBelma TuranCurrent Pharmaceutical Biotechnology|September 30, 2010
Flavonoid rich fraction of Dioscorea bulbifera Linn. (Yam) enhances mitochondrial enzymes and antioxidant status and thereby protects heart from isoproterenol induced myocardial infarctionK S Jayachandran, Hannah R Vasanthi, G V RajamanickamaCurrent Pharmaceutical Biotechnology|September 3, 2010
Open access high throughput drug discovery in the public domain: a Mount Everest in the makingAnuradha Roy, Peter R McDonald, Sitta Sittampalam, et al.Current Pharmaceutical Biotechnology|November 4, 2010
Cancer cell reprogramming: stem cell differentiation stage factors and an agent based model to optimize cancer treatmentPier Mario Biava, M Basevi, L Biggiero, et al.Current Pharmaceutical Biotechnology|November 4, 2010
An update on hepatic stem cells: bench to bedsideN Parveen, A K Aleem, M A Habeeb, et al.Current Pharmaceutical Biotechnology|January 18, 2011
Mucopolysaccharidosis Type II (Hunter Syndrome): clinical picture and treatmentMichael BeckCurrent Pharmaceutical Biotechnology|January 18, 2011
On the involvement of H2S in nitroso signaling and other mechanisms of H2S actionZuzana Tomaskova, Anna Bertova, Karol OndriasCurrent Pharmaceutical Biotechnology|January 18, 2011
Exercise-induced modulation of endothelial nitric oxide productionStephan Gielen, Marcus Sandri, Sandra Erbs, et al.Current Pharmaceutical Biotechnology|October 12, 2010
A "cute" desensitization of TRPV1Filip Touska, Lenka Marsakova, Jan Teisinger, et al.Current Pharmaceutical Biotechnology|October 14, 2010
The therapeutic implications of renin-angiotensin system blockade in diabetic retinopathyV Swetha E JeganathanPageof 303